Authors’ responses to letter to the editor re: “Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1)”

Betty S. ChanClinical Toxicology Unit & Emergency Department, Prince of Wales Hospital, Sydney, NSW, Australia;New South Wales Poisons Information Centre, Sydney, AustraliaCorrespondence[email protected]

Angela ChiewClinical Toxicology Unit & Emergency Department, Prince of Wales Hospital, Sydney, NSW, Australia;New South Wales Poisons Information Centre, Sydney, Australia

Geoffrey K. IsbisterNew South Wales Poisons Information Centre, Sydney, Australia;Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia;Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Australia

Margaret O’LearyClinical Toxicology Research Group, University of Newcastle, Newcastle, Australia;Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Australia

Nicholas A. BuckleyNew South Wales Poisons Information Centre, Sydney, Australia;Clinical Pharmacology, University of Sydney, Sydney, Australia

"Authors’ responses to letter to the editor re: “Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1)”." Clinical Toxicology, 55(1), p. 64

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Funding

Geoff Isbister – The study was supported by an NHMRC Program [Grant 1055176]. Geoff Isbister is funded by an NHMRC Senior Research Fellowship ID1061041.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Authors’ responses to letter to the editor re: “Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1)”

Information for

Open access

Opportunities

Help and information

Authors’ responses to letter to the editor re: “Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1)”

Disclosure statement

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature